SCHEMBL5898523

SCHEMBL5898523

CCC(O)(CC(N)=O)c1ccc(Br)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
OGG1 O15527 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
HDAC3 O15379 3/20 0.36
HDAC1 Q13547 3/20 0.36
HDAC2 Q92769 3/20 0.36
EPHX1 P07099 2/20 0.35
POLB P06746 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
GAA P10253 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5898567 0.83 ALDH1A1 (0.38) SMN1; SMN2OGG1MEN1KMT2AALDH1A1
SCHEMBL8358159 0.83 MAPT (0.45) MEN1KMT2AALDH1A1TSHRPOLB
SCHEMBL8363409 0.83 KCNN4 (0.52) SMN1; SMN2MEN1KMT2A
SCHEMBL5898588 0.82 MAPT (0.46) SMN1; SMN2KMT2AKIF11
SCHEMBL1056429 0.81 ALDH1A1 (0.44) SMN1; SMN2OGG1ALDH1A1TP53TSHR
SCHEMBL5898550 0.79 KMT2A (0.46) SMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL15066878 0.77 SMN1; SMN2 (0.43) SMN1; SMN2OGG1MEN1KMT2AALDH1A1
SCHEMBL23893792 0.76 ALDH1A1 (0.41) OGG1ALDH1A1TP53TSHRHDAC3
SCHEMBL5898527 0.76 TSHR (0.39) SMN1; SMN2MEN1KMT2ATSHRHDAC3
SCHEMBL5898573 0.75 OGG1 (0.41) SMN1; SMN2OGG1MEN1KMT2AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity MEZA TOLEDO SERGIO E 2006-12-21 US disclosed
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity MEZA TOLEDO SERGIO E 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity GABRB2, HRH3, HRH4 SMN1; SMN2 2748/4885OGG1 4127/4885MEN1 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.